GCT vs HIMX

GCT presents a compelling value proposition with a Piotroski F-Score of 4/9 indicating stable financial health and a current price ($46.50) significantly below its growth-based intrinsic value of $107.97. The company exhibits exceptional profitability with an ROE of 30.84% and a very low P/E ratio of 12.70 relative to the technology sector average. However, this fundamental strength is heavily countered by aggressive insider selling and a bearish technical trend. The massive earnings surprise track record suggests the market may still be underestimating the company's growth trajectory.

HIMX exhibits a strong operational health profile with a Piotroski F-Score of 7/9, yet this is overshadowed by severe fundamental deterioration. The stock is significantly overvalued relative to its Graham Number ($5.47) and Intrinsic Value ($1.82), while trading at a high P/E of 35.42 despite crashing YoY earnings (-74.20%) and revenue (-14.40%). Most critically, the dividend is unsustainable with a payout ratio of 142.31%, indicating the company is returning more capital than it generates.